EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

What is the real value of omics data? Enhancing research outcomes and securing long-term data excellence

Eva Price, Felix Feyertag, Thomas Evans, James Miskin, Kyriacos Mitrophanous, Duygu Dikicioglu iD

Nucleic Acids Research · 11.11.2024 · 52 (20) · 12130-12140

DOI: 10.1093/nar/gkae901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.10.2024. Verfasst von Eva Price und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Engineering, University College London, Gower Street, London WC1E 6BT, UK. Hauptthemen laut MEDLINE: Genomics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI, UCL, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A wealth of high-throughput biological data, of which omics constitute a significant fraction, has been made publicly available in repositories over the past decades. These data come in various formats and cover a range of species and research areas providing insights into the complexities of biological systems; the public repositories hosting these data serve as multifaceted resources. The potentially greater value of these data lies in their secondary utilization as the deployment of data science and artificial intelligence in biology advances. Here, we critically evaluate challenges in secondary data use, focusing on omics data of human embryonic kidney cell lines available in public repositories. The emerging issues are obstacles faced by secondary data users across diverse domains as they concern platforms and repositories, which accept deposition of data irrespective of their species type. The evolving landscape of data-driven research in biology prompts re-evaluation of open access data curation and submission procedures to ensure that these challenges do not impede novel research opportunities through data exploitation. This paper aims to draw attention to widespread issues with data reporting and encourages data owners to meticulously curate submissions to maximize not only their immediate research impact but also the long-term legacy of datasets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenomicsHumansData CurationComputational BiologyHEK293 CellsProteomics

Autor:innen und Institutionen

  • Department of Biochemical Engineering, University College London, Gower Street, London WC1E 6BT, UK.
  • Oxford Biomedica (UK) Ltd, Windrush Court, Transport Way, Oxford OX4 6LT, UK.

ORCID-Profile: Duygu Dikicioglu

Förderung

  • UKRI
  • UCL
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Price, E., Feyertag, F., Evans, T., Miskin, J., Mitrophanous, K., & Dikicioglu, D. (2024). What is the real value of omics data? Enhancing research outcomes and securing long-term data excellence. Nucleic Acids Research, 52(20), 12130-12140. https://doi.org/10.1093/nar/gkae901

Vancouver

Price E, Feyertag F, Evans T, Miskin J, Mitrophanous K, Dikicioglu D. What is the real value of omics data? Enhancing research outcomes and securing long-term data excellence. Nucleic Acids Research. 2024;52(20):12130-12140. doi:10.1093/nar/gkae901

BibTeX
@article{Price2024,
  author = {Price, Eva and Feyertag, Felix and Evans, Thomas and Miskin, James and Mitrophanous, Kyriacos and Dikicioglu, Duygu},
  title = {What is the real value of omics data? Enhancing research outcomes and securing long-term data excellence},
  journal = {Nucleic Acids Research},
  year = {2024},
  volume = {52},
  number = {20},
  pages = {12130--12140},
  doi = {10.1093/nar/gkae901}
}
Kostenlos starten →